Medicare Enrolled

Dr. Kenneth Peters, MD

Urology Physician · Royal Oak, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
3601 W 13 MILE RD, Royal Oak, MI 48073
2488980898
In practice since 2005 (20 years)
NPI: 1417948944 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Peters from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peters? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Peters

Dr. Kenneth Peters is an urology physician in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Peters performed 378 Medicare services across 341 unique beneficiaries.

Between the years covered by Open Payments, Dr. Peters received a total of $16,738 from 32 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Peters is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 378 Medicare services $16,738 industry payments

Medicare Practice Summary

Medicare Utilization ↗
378
Medicare services
Bottom 33% in MI for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
341
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~19 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electronic analysis of implanted neurostimulator
This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation.
54 $31 $128
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
38 $51 $296
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
35 $63 $269
Imaging guidance for procedure, 60 minutes or less
Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less.
34 $13 $107
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $51 $217
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
27 $2 $10
Radiologist review of bladder and urethra images with contrast
A radiologist reviews medical images of the urinary bladder and urethra taken with contrast dye, including images captured after the patient has urinated.
20 $12 $214
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $109 $440
Voiding cystourethrogram
An imaging procedure that uses X-rays to visualize the bladder and urethra while urine is being passed.
18 $18 $203
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
18 $84 $638
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
18 $32 $316
Insertion of peripheral or gastric neurostimulator generator
A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach.
17 $105 $540
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
14 $7 $41
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
13 $15 $62
Electromyography of bladder and bowel sphincters
A test that measures and records the electrical activity of muscles at the bladder and bowel openings using a needle.
12 $41 $750
Sacral nerve stimulator electrode insertion
A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves.
11 $262 $1,669
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,738
Total received (2018-2024)
Avg $2,391/year across 7 years
Top 12% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,972 (53.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,918 (35.4%)
Scientific / Research
Research funding and grants
$1,500 (9.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$348 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,011
2023
$866
2022
$8,912
2021
$260
2020
$1,082
2019
$3,320
2018
$288

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$1,668
Medtronic, Inc.
$156
Laborie Medical Technologies Corp.
$82
Boston Scientific Corporation
$46
Curonix LLC
$27
C. R. Bard, Inc. & Subsidiaries
$17
ABBVIE INC.
$14
Top 3 companies account for 94.8% of 2024 payments
All-time payments by company (2018-2024) ›
UROVANT SCIENCES INC
$8,408
COLOPLAST CORP
$1,668
Boston Scientific Corporation
$1,569
Medtronic USA, Inc.
$1,502
Coloplast Corp
$653
Inspire Medical Systems, Inc.
$564
Medtronic, Inc.
$558
Stimwave Technologies Incorporated
$436
Astellas Pharma US Inc
$349
Allergan, Inc.
$153
Axonics, Inc.
$108
Avadel Specialty Pharmaceuticals, LLC
$91
Laborie Medical Technologies Corp.
$82
Contura, Inc.
$77
Axonics Modulation Technologies, Inc.
$68
Allergan Inc.
$52
Olympus America Inc.
$51
AMAG Pharmaceuticals, Inc.
$48
Rochester Medical Corporation
$44
C. R. Bard, Inc. & Subsidiaries
$34
Curonix LLC
$27
Janssen Biotech, Inc.
$27
Merck Sharp & Dohme LLC
$23
180 Medical, Inc.
$21
Dendreon Pharmaceuticals LLC
$19
Clarus Therapeutics Inc.
$17
PFIZER INC.
$16
BAXTER HEALTHCARE
$16
Smith+Nephew, Inc.
$15
ABBVIE INC.
$14
Sagent Pharmaceuticals, Inc.
$13
TOLMAR Pharmaceuticals, Inc.
$12
Top 3 companies account for 69.6% of all-time payments
Associated products mentioned in payments ›
Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · ELIGARD · Erleada · GEMTESA · GENERAL - FEMALE SUI · Genesis · Glydo · INTERSTIM · INTERSTIM ICON · INTRAROSA · Inspire Upper Airway Stimulation System · JATENZO · KEYTRUDA · MYRBETRIQ · Noctiva · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROVENGE · Personal Catheter Intermittent Catheter · SPEEDICATH · STRAVIX · TISSEEL · TOVIAZ · XTANDI · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for an urology physician in Royal Oak?
Compare urology physicians in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
172
Per 100K population
13.5
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Peters is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 12% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Peters experienced with electronic analysis of implanted neurostimulator?
Based on Medicare claims data, Dr. Peters performed 54 electronic analysis of implanted neurostimulator services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peters receive payments from pharmaceutical companies?
Yes. Dr. Peters received a total of $16,738 from 32 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peters's costs compare to other urology physicians in Royal Oak?
Dr. Peters's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peters) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →